| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 07/25/2012 | CN102604889A HEK (human embryonic kidney) 293 cell line applicable to serum-free culture and application thereof |
| 07/25/2012 | CN102603874A Recombinant HA (Hyaluronic Acid) protein for detecting H5 subtype avian influenza virus and encoding gene thereof |
| 07/25/2012 | CN102600481A Adenovirus (rAdV)/Japanese encephalitis virus (JEV) replicon embedding carrier hog cholera vaccine and application of rAdV/ JEV replicon embedding carrier hog cholera vaccine |
| 07/25/2012 | CN102600464A Avian influenza virus inactivated vaccine and preparation method thereof |
| 07/25/2012 | CN102168074B Recombinant adenovirus and application thereof |
| 07/25/2012 | CN102154213B Novel cytokine-induced killer (CIK) cells for carrying cytokine loaded double-regulated oncolytic adenovirus |
| 07/25/2012 | CN101948813B Method for separating stichopus japonicas spherical viruses |
| 07/25/2012 | CN101921769B Recombinant adenovirus, preparation method and application thereof |
| 07/25/2012 | CN101897963B Vaccine for hand-foot-and-mouth disease viruses |
| 07/25/2012 | CN101818130B gG and TK gene-deleted recombinant infectious bovine rhinotracheitis virus and application |
| 07/25/2012 | CN101748122B Disturbing molecule for inhibiting expression of TM4SF4 and application thereof |
| 07/24/2012 | US8227237 Engineered CO2 fixing microorganisms producing carbon-based products of interest |
| 07/24/2012 | US8227185 Non-M, non-O HIV-1 strains, fragments and uses |
| 07/24/2012 | CA2471822C Cell-specific herpes simplex virus expression/replication vector comprising icp4 and human calponin gene promoter |
| 07/19/2012 | WO2012067483A3 Newcastle disease virus and the use thereof as a vaccine |
| 07/19/2012 | WO2012065105A3 Chimeric flavivirus vaccines |
| 07/19/2012 | WO2012060678A3 Novel vaccines against the a/h1n1 pandemic flu virus |
| 07/19/2012 | WO2011038473A8 Method, kit, plasmid and composition for inducing an immune response to dengue virus, on the basis of dna and chimeric virus vaccines |
| 07/19/2012 | US20120184602 Metabolically activated recombinant viral vectors and methods for their preparation and use |
| 07/19/2012 | US20120183574 Modified vaccinia virus ankara for the vaccnation of neonates |
| 07/18/2012 | EP2475768A1 Method for the preparation of an influenza virus |
| 07/18/2012 | EP1437961B1 Methods of suppressing microglial activation |
| 07/18/2012 | CN102596996A Antibody having activity of inhibiting infection with hepatitis c virus (hcv) and use of same |
| 07/18/2012 | CN102596244A 丙型肝炎病毒疫苗组合物 HCV vaccine composition |
| 07/18/2012 | CN102586199A Defective influenza virus particles |
| 07/18/2012 | CN102586198A Recombinant adenovirus capable of resisting foot and mouth disease virus replication and infection as well as preparation method and application of recombinant adenovirus |
| 07/18/2012 | CN102586197A Method for nanometer adsorption and enrichment of water viruses in living water of large-volume aquatic animals and kit |
| 07/18/2012 | CN102586196A H1N1 subtype swine influenza virus and application thereof |
| 07/18/2012 | CN102586195A Method for preparing avian influenza virus and inactivated vaccine thereof with Vero passage cells |
| 07/18/2012 | CN102586194A H9 subtype avian influenza virus Vero cell adapted strain and application thereof |
| 07/18/2012 | CN102584947A Antibodies directed against hepatitis c virus E1E2 complex, compositions of HCV particles, and pharmaceutical compositions |
| 07/18/2012 | CN102002481B Production method of porcine reproductive and respiratory syndrome virus |
| 07/18/2012 | CN101792743B Recombinant baculovirus expressing porcine circovirus type 2 (PCV-2) immunogen gene and preparation method and application thereof |
| 07/17/2012 | US8221971 Altering human immune response to adenoviral vector via modification of capsid proteins; improved exogenous gene expression |
| 07/17/2012 | US8221969 Method of producing virus |
| 07/17/2012 | US8221769 Microorganisms for therapy |
| 07/17/2012 | CA2624544C Vero cell line adapted to grow in suspension |
| 07/17/2012 | CA2499355C Compositions, methods and kits for detection of an antigen on a cell and in a biological mixture |
| 07/17/2012 | CA2410948C Method for the purification of alphavirus replicon particles |
| 07/12/2012 | US20120178791 MODULATION OF HUMAN CYTOMEGALOVIRUS REPLICATION BY MICRO-RNA 132 (miR132), MICRO-RNA 145 (miR145) AND MICRO-RNA 212 (miR212) |
| 07/12/2012 | US20120178157 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome |
| 07/12/2012 | US20120178145 Virus scaffold for self-assembled, flexible and light lithium battery |
| 07/12/2012 | US20120177675 Chimaeric Protein |
| 07/12/2012 | US20120177608 Pseudomonas aeruginosa bacteriophage(s) and uses thereof |
| 07/12/2012 | CA2824277A1 Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus |
| 07/11/2012 | EP2473599A1 Bovine herpesvirus vaccine |
| 07/11/2012 | EP2001459B1 Methods and compositions for inducing an immune response to hiv and models for testing |
| 07/11/2012 | EP1766059B1 Influenza hemagglutinin and neuraminidase variants |
| 07/11/2012 | CN102575233A Process for adenovirus purification from high cell density cultures |
| 07/11/2012 | CN102575232A Simian adenovirus 41 and uses thereof |
| 07/11/2012 | CN102574897A Chimaeric protein |
| 07/11/2012 | CN102573943A Composition for inducing tissue regeneration by activating platelet-rich plasma (PRP), and method for manufacturing same |
| 07/11/2012 | CN102565390A Preparation process of antigen for diagnosing newcastle disease |
| 07/11/2012 | CN102559859A Method for using 5-flucytosine for real-time monitoring of deoxyribonucleic acid (DNA) deamination process of human immunodeficiency virus-1 (HIV-1) |
| 07/11/2012 | CN102559760A Construction method for linearized shuttle vector BmBacmid |
| 07/11/2012 | CN102559758A Vector for preparing adenovirus of which hexon is subjected to genetic modification and method for constructing vector |
| 07/11/2012 | CN102559754A Preparation method and application of EV71 type full length infectious clone with luciferase tag |
| 07/11/2012 | CN102559617A Method of bioreactor micro-carrier for cultivating human diploid cell to produce viral vaccine |
| 07/11/2012 | CN102559616A Norovirus RNA fragment-containing pseudoviral particle and preparation method thereof |
| 07/11/2012 | CN102559615A Preparation method of EV71 vaccine and vaccine prepared by preparation method |
| 07/11/2012 | CN102559614A Classical swine fever vaccine and preparation method thereof |
| 07/11/2012 | CN102559613A Malignant malaria vaccine and preparation method thereof |
| 07/11/2012 | CN102559612A Recombinant newcastle disease virus LaSota vaccine strain for expressing Nipah virus encephalitis G-protein |
| 07/11/2012 | CN102559611A Double-expression recombinant modified vaccinia virus Ankara (MVA) without selection marker and construction method for virus |
| 07/11/2012 | CN102559610A Recombined duck virus enteritis viral vaccine strain CCTCC for expressing bird flu virus hemagglutinin (HA) gene (rDEVus78Ha) as well as establishing method and application thereof |
| 07/11/2012 | CN102559609A Recombined adenovirus vaccine for preventing AIDS |
| 07/11/2012 | CN102559608A Method for separating and culturing RSV (Respiratory Syncytial Virus) by using OMC (Ostiomeatal Complex)-685-1 cells |
| 07/11/2012 | CN102559607A Newcastle disease virus high mucosal immunity level lentogen vaccine strain NDV/LX and reverse genetic construction system |
| 07/11/2012 | CN102559606A A16 type strain of Coxsackie virus and application of the strain |
| 07/11/2012 | CN102559599A Vero-SIAT1 cell line and application thereof |
| 07/11/2012 | CN102552937A Application of human p21-activated kinase 7 (PAK7) gene and relevant medicines of human PAK7 gene |
| 07/11/2012 | CN102552899A Method for preparing rabies vaccine by perfusion culture of bioreactor |
| 07/11/2012 | CN102552898A Purification preparation method of human rotavirus inactivated vaccines by utilizing ion exchange chromatography |
| 07/11/2012 | CN102552892A Mannan-modified hTRT (human Telomerase Reverse Transcriptase) gene-carrying and adeno-associated virus (AAV)-inducing targeting dendritic cell (DC) vaccine and preparation method thereof |
| 07/11/2012 | CN102550490A Method of raising ectropis oblique warren through sambucus chinensis and Ectropis grisescens nucleopolyhedrovirus (EcobNPV) propagation method utilizing same |
| 07/11/2012 | CN102550458A Technique for allowing aquatic invertebrate larvae and parents to harmlessly carry Vibrio phages |
| 07/11/2012 | CN101905019B Porcine hemagglutinating encephalomyelitis cell culture inactivated vaccine and preparation method thereof |
| 07/11/2012 | CN101892202B Biotin labeling method of envelope viruses |
| 07/11/2012 | CN101570571B Truncated human papilloma virus 18 type L1 protein |
| 07/11/2012 | CN101559224B Poliomyelitis vaccine |
| 07/11/2012 | CN101525597B New hepatitis A inactivated vaccine virus strain and method for culturing same |
| 07/10/2012 | US8217019 AIDS virus vaccines using Sendai virus vector |
| 07/10/2012 | US8216834 Chimpanzee adenovirus vaccine carriers |
| 07/10/2012 | US8216819 Generation of oncolytic adenoviruses and uses thereof |
| 07/10/2012 | US8216564 Herpes simplex virus (HSV) derived amplicon defective viral genome carrying at least one toxic foreign gene and an HSV-derived mutant helper virus; antitumor and anticarcinogenic agents |
| 07/10/2012 | CA2305816C Peptides capable of inhibiting the interaction between presenilins and the .beta.-amyloid peptide or its precursor |
| 07/05/2012 | WO2012090000A1 Inactivated poliovaccine |
| 07/05/2012 | WO2012089348A1 Means for generating adenoviral vectors for cloning large nucleic acids |
| 07/05/2012 | WO2012088763A1 Hepatitis a virus strain sh and method for adapting same to diploid cells |
| 07/05/2012 | US20120174263 Production of viral capsids |
| 07/05/2012 | US20120172418 Aslv vector system |
| 07/05/2012 | US20120171750 Purification of vaccinia viruses using hydrophobic interaction chromatography |
| 07/05/2012 | US20120171724 High yield suspension cell line, system, and method for making same |
| 07/05/2012 | US20120171660 Method for screening and purifying enterovirus, method for mass-producing enterovirus, and method for manufacturing enterovirus vaccine |
| 07/05/2012 | US20120171246 Immunization to reduce neurotoxicity during treatment with cytolytic viruses |
| 07/05/2012 | US20120171243 Method of preparing live viral vaccines by genetic engineering of viral genome |
| 07/05/2012 | CA2823886A1 Means for generating adenoviral vectors for cloning large nucleic acids |
| 07/05/2012 | CA2821859A1 Inactivated poliovaccine |
| 07/05/2012 | CA2754477A1 Method for screening and purifying enterovirus, method for mass-producing enterovirus, and method for manufacturing enterovirus vaccine |
| 07/04/2012 | EP2471938A2 Recombinant polyvalent vaccine |